Realm Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Realm Therapeutics's estimated annual revenue is currently $620k per year.
- Realm Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Realm Therapeutics has 4 Employees.
- Realm Therapeutics grew their employee count by 0% last year.
Realm Therapeutics's People
Name | Title | Email/Phone |
---|
Realm Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Realm Therapeutics?
Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children. The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations. The Company believes its formulations have novel immunomodulatory activity with potential application for the treatment of diseases in a number of therapeutic areas, including Dermatology and Ophthalmology. Realm Therapeutics is advancing its immunomodulatory technology against inflammatory diseases with high unmet needs in Dermatology and Ophthalmology. The Company has developed proprietary formulations of our novel technology for initial application in Atopic Dermatitis (PR022), Acne (PR023) and Allergic Conjunctivitis (PR013), as reflected in our pipeline chart at @ www.realmtx.com
keywords:N/AN/A
Total Funding
4
Number of Employees
$620k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 4 | 100% | N/A |
#2 | $0.7M | 5 | -17% | N/A |
#3 | $0.4M | 5 | -44% | N/A |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 6 | 0% | N/A |